Wells Fargo’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-675
Closed 6872
2019
Q1
$0 Sell
675
-1
-0.1% -$1 ﹤0.01% 6795
2018
Q4
$0 Hold
676
﹤0.01% 6883
2018
Q3
$1K Hold
676
﹤0.01% 6359
2018
Q2
$1K Sell
676
-67
-9% -$100 ﹤0.01% 6288
2018
Q1
$1K Hold
743
﹤0.01% 6324
2017
Q4
$1K Sell
743
-1,716
-70% -$3.55K ﹤0.01% 6306
2017
Q3
$6K Buy
2,459
+1,500
+156% +$5.07K ﹤0.01% 6003
2017
Q2
$3K Sell
959
-4,715
-83% -$16.1K ﹤0.01% 6028
2017
Q1
$15K Sell
5,674
-833
-13% -$2.11K ﹤0.01% 5782
2016
Q4
$14K Buy
6,507
+1,500
+30% +$4.41K ﹤0.01% 5725
2016
Q3
$17K Sell
5,007
-700
-12% -$3.21K ﹤0.01% 5650
2016
Q2
$76K Sell
5,707
-1,857
-25% -$30.9K ﹤0.01% 4993
2016
Q1
$122K Buy
7,564
+1,693
+29% +$23.1K ﹤0.01% 4703
2015
Q4
$93K Sell
5,871
-15
-0.3% -$257 ﹤0.01% 4968
2015
Q3
$84K Sell
5,886
-418
-7% -$7.08K ﹤0.01% 5013
2015
Q2
$141K Buy
6,304
+4,875
+341% +$122K ﹤0.01% 4815
2015
Q1
$29K Buy
1,429
+769
+117% +$14.3K ﹤0.01% 5246
2014
Q4
$11K Sell
660
-49
-7% -$764 ﹤0.01% 5609
2014
Q3
$11K Sell
709
-3,832
-84% -$75.7K ﹤0.01% 5565
2014
Q2
$115K Sell
4,541
-2,000
-31% -$45.6K ﹤0.01% 4626
2014
Q1
$137K Buy
6,541
+6,229
+1,996% +$221K ﹤0.01% 4511
2013
Q4
$12K Buy
312
+216
+225% +$3.93K ﹤0.01% 5163
2013
Q3
$2K Hold
96
﹤0.01% 5493
2013
Q2
$1K Buy
+96
New +$1.42K ﹤0.01% 5533

Other funds holding CYTR

Wells Fargo's CYTR Position: Q2 2019 in Review

Wells Fargo sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 675 shares.

Wells Fargo first reported a position in CYTR in Q2 2013 and held it in 24 quarters. The position peaked at $141K in Q2 2015. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • Wells Fargo reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • Wells Fargo sold 675 CytRx Corp shares in Q2 2019.
  • Wells Fargo first reported a position in CytRx Corp in Q2 2013 and held it in 24 quarters.
  • Wells Fargo's CytRx Corp position peaked at $141K in Q2 2015.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Wells Fargo's 13F filing for Q2 2019, filed 6 Aug 2019.